GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » Sale Of Investment

Edwards Lifesciences (FRA:EWL) Sale Of Investment : €572 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Edwards Lifesciences Sale Of Investment?

Edwards Lifesciences's sale of investment for the three months ended in Mar. 2024 was €153 Mil. It means Edwards Lifesciences gained €153 Mil from selling investments. Edwards Lifesciences's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €572 Mil.

Compared with last quarter (€126 Mil in Dec. 2023 ), Edwards Lifesciences gained more money from selling investments in Mar. 2024 (€153 Mil).

Edwards Lifesciences Sale Of Investment Historical Data

The historical data trend for Edwards Lifesciences's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Sale Of Investment Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 368.91 638.69 468.34 1,282.99 656.39

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 246.48 123.77 169.04 126.00 153.27

Edwards Lifesciences Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €572 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (FRA:EWL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » Sale Of Investment
Comparable Companies
DXCM ZBH ALGN STE SWAV BRKR PODD PEN BIO MASI ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.